
AiCella, Inc. is a biotechnology company specializing in revolutionizing CAR-T therapy development through advanced AI-driven tools and process optimization. Their flagship product, the InsightsTM data dashboard, integrates seven AI/ML algorithms to analyze and visualize critical process parameters, connecting patient clinical responses to manufacturing variables. AiCella supports clients with cGMP-oriented process development, wet-lab verification of AI-generated recommendations, SOPs with best practices, tech transfer assistance to CDMOs, and regulatory IND filing support. Their AI-powered platform enhances decision-making, streamlines R&D to clinical transition, and aids intellectual property filings, targeting pharmaceutical companies, biotech firms, academic and research institutions in the personalized cancer therapy market.

AiCella, Inc. is a biotechnology company specializing in revolutionizing CAR-T therapy development through advanced AI-driven tools and process optimization. Their flagship product, the InsightsTM data dashboard, integrates seven AI/ML algorithms to analyze and visualize critical process parameters, connecting patient clinical responses to manufacturing variables. AiCella supports clients with cGMP-oriented process development, wet-lab verification of AI-generated recommendations, SOPs with best practices, tech transfer assistance to CDMOs, and regulatory IND filing support. Their AI-powered platform enhances decision-making, streamlines R&D to clinical transition, and aids intellectual property filings, targeting pharmaceutical companies, biotech firms, academic and research institutions in the personalized cancer therapy market.